Dosimetric Comparisons of Volumetric Modulated Arc Therapy and Tomotherapy for Early T-Stage Nasopharyngeal Carcinoma.
Shan LiQin ZhouLiang-Fang ShenHuan LiZhan-Zhan LiZhen YangMing-Jun LeiXiao-Yu YangZi-Jian ZhangYong-Mei HuZe-Fu JinGui LiuZhi-Ping LvXin-Qiong HuangPublished in: BioMed research international (2018)
Our results show that RapidArc and HT are comparable in D98, dose homogeneity, and protection of the spinal cord and pituitary gland. RapidArc performs better in shortening delivery time, lowering MUs, and sparing the optic nerve and optic chiasm. HT is superior in dose conformity and protection of the brain stem, temporal lobe, lens, and parotid.